Cyclooxygenase isozymes and their gene structures and expression

被引:357
作者
Tanabe, T [1 ]
Tohnai, N [1 ]
机构
[1] Natl Cardiovasc Ctr, Inst Res, Dept Pharmacol, Suita, Osaka 5658565, Japan
来源
PROSTAGLANDINS & OTHER LIPID MEDIATORS | 2002年 / 68-9卷
关键词
cyclooxygenase; isozyme; signaling pathways;
D O I
10.1016/S0090-6980(02)00024-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cyclooxygenase (COX, prostaglandin endoperoxide synthase) is a key enzyme in prostaglandin biosynthesis. Two isoforms of COX, COX-1 and COX-2, have been identified by molecular biological methods. The amino acid sequence homology between COX-1 and COX-2 is about 60% for the human enzymes. COX-1 is constitutively expressed in most tissues and cells in animal species. The COX-1 promoter region lacks a canonical TATA or CAAT box and is GC-rich. These features are consistent with those of a housekeeping gene. On the other hand, COX-2 is an inducible enzyme and is induced by various cytokines and mitogenic factors. The induction of COX-2 is suppressed by dexamethasone and PGJ(2). There are many consensus cis-elements in the 5'-flanking region to regulate the expression of COX-2. Among them, a CRE, an NF-kappaB site, a NF-IL6 motif and an E-box, regulate transcription independently or synergistically. Most of the transcriptional signaling pathways require activation of the mitogen-activated protein kinase (MAPK) cascade. Moreover, MAPK signaling pathways are involved in regulating COX-2 gene expression at the post-transcriptional level. (C) 2002 Published by Elsevier Science Inc.
引用
收藏
页码:95 / 114
页数:20
相关论文
共 120 条
  • [1] Cyclooxygenase-2 inhibitor NS-398 protects neuronal cultures from lipopolysaccharide-induced neurotoxicity
    Araki, E
    Forster, C
    Dubinsky, JM
    Ross, ME
    Iadecola, C
    [J]. STROKE, 2001, 32 (10) : 2370 - 2375
  • [2] Prostaglandin G/H synthase-2 is the constitutive and dominant isoform in cultured human lung epithelial cells
    Asano, K
    Lilly, CM
    Drazen, JM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1996, 271 (01) : L126 - L131
  • [3] IMMUNOSUPPRESSION BY GLUCOCORTICOIDS - INHIBITION OF NF-KAPPA-B ACTIVITY THROUGH INDUCTION OF I-KAPPA-B SYNTHESIS
    AUPHAN, N
    DIDONATO, JA
    ROSETTE, C
    HELMBERG, A
    KARIN, M
    [J]. SCIENCE, 1995, 270 (5234) : 286 - 290
  • [4] NF-kappa B: Ten years after
    Baeuerle, PA
    Baltimore, D
    [J]. CELL, 1996, 87 (01) : 13 - 20
  • [5] The NF-kappa B and I kappa B proteins: New discoveries and insights
    Baldwin, AS
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 : 649 - 683
  • [6] Expression and regulation of cyclooxygenase-2 in rat microglia
    Bauer, MKA
    Lieb, K
    SchulzeOsthoff, K
    Berger, M
    GebickeHaerter, PJ
    Bauer, J
    Fiebich, BL
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 243 (03): : 726 - 731
  • [7] Control of transcription by steroid hormones
    Beato, M
    Truss, M
    Chavez, S
    [J]. BASIS FOR CANCER MANAGEMENT, 1996, 784 : 93 - 123
  • [8] Enhanced bradykinin-stimulated prostaglandin release in the acutely inflamed guinea pig gallbladder is due to new synthesis of cyclooxygenase 1 and prostacyclin synthase
    Bogar, LJ
    Bartula, LL
    Parkman, HP
    Myers, SI
    [J]. JOURNAL OF SURGICAL RESEARCH, 1999, 84 (01) : 71 - 76
  • [9] THE PATHOGENESIS OF SEPSIS
    BONE, RC
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 115 (06) : 457 - 469
  • [10] Vascular endothelial growth factor upregulates constitutive cyclooxygenase 1 in primary bovine and human endothelial cells
    Bryant, CE
    Appleton, I
    Mitchell, JA
    [J]. LIFE SCIENCES, 1998, 62 (24) : 2195 - 2201